These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 28128737)
21. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer. Tian Y; Feng Y Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874 [TBL] [Abstract][Full Text] [Related]
23. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway. Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients. Zhang Y; Zhao Y; Sun S; Liu Z; Zhang Y; Jiao S Tumour Biol; 2016 Aug; 37(8):10155-60. PubMed ID: 26831656 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC. Liu L; Qu W; Zhong Z Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272 [TBL] [Abstract][Full Text] [Related]
26. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
27. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer. Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367 [TBL] [Abstract][Full Text] [Related]
28. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers. Ryuge S; Sato Y; Nagashio R; Hiyoshi Y; Katono K; Igawa S; Nakashima H; Shiomi K; Ichinoe M; Murakumo Y; Saegusa M; Satoh Y; Masuda N PLoS One; 2017; 12(3):e0173886. PubMed ID: 28358810 [TBL] [Abstract][Full Text] [Related]
30. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777 [TBL] [Abstract][Full Text] [Related]
32. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis. Wang H; Xie F; Hu Z; Chen L Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435 [TBL] [Abstract][Full Text] [Related]
33. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
34. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer. Rong B; Nan Y; Liu H; Gao W Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798 [TBL] [Abstract][Full Text] [Related]
35. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer. Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802 [TBL] [Abstract][Full Text] [Related]
36. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma. Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696 [TBL] [Abstract][Full Text] [Related]
37. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer. Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414 [TBL] [Abstract][Full Text] [Related]
39. Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer. Sun Y; Han Y; Wang X; Wang W; Wang X; Wen M; Xia J; Xing H; Li X; Zhang Z Oncol Rep; 2016 Aug; 36(2):1030-40. PubMed ID: 27350337 [TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]